{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:07:44Z","timestamp":1793070464169,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtho.2025.09.013","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:06:53Z","timestamp":1758600413000},"page":"77-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of Autoimmune Conditions Associated With Thymic Epithelial Tumors"],"prefix":"10.1016","volume":"21","author":[{"given":"Waqas","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Pietroluongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwairiyyah","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iemaan","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bestvina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Garassino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2025.09.013_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","article-title":"The spectrum of diseases associated with thymoma. Coincidence or syndrome?","volume":"134","author":"Souadjian","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1308989","article-title":"Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999\u20132019","volume":"13","author":"Gerber","year":"2024","journal-title":"Front Oncol"},{"issue":"suppl 2","key":"10.1016\/j.jtho.2025.09.013_bib3","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1097\/JTO.0000000000000299","article-title":"Alterations of the immune system in thymic malignancies","volume":"9","author":"Weksler","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and autoimmunity","volume":"8","author":"Shelly","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.athoracsur.2004.06.090","article-title":"Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan","volume":"79","author":"Kondo","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib6","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.21037\/jtd-2019-thym-10","article-title":"Autoimmune disorders and paraneoplastic syndromes in thymoma","volume":"12","author":"Blum","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2025.09.013_bib7","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.21037\/jtd.2018.07.14","article-title":"Pure red cell aplasia associated with thymoma: a report of a single-center experience","volume":"10","author":"Moriyama","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2025.09.013_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.01.006","article-title":"Good\u2019s syndrome remains a mystery after 55 years: a systematic review of the scientific evidence","volume":"135","author":"Kelesidis","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1468-1331.2003.00686.x","article-title":"HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis","volume":"10","author":"Garc\u00eda-Ramos","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jtho.2025.09.013_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clim.1999.4710","article-title":"Correlation of thymic pathology with HLA in myasthenia gravis","volume":"91","author":"Machens","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.02.004","article-title":"Association of HLA-A in autoimmune myasthenia gravis with thymoma","volume":"210","author":"Vandiedonck","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2008.11.040","article-title":"Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches","volume":"87","author":"Meyer","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ane.13332","article-title":"Thymomatous myasthenia gravis: 10-year experience of a Single Center","volume":"143","author":"Chen","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jtho.2025.09.013_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2025.09.013_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejcts.2010.09.042","article-title":"Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience","volume":"40","author":"Ruffini","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s13193-013-0214-2","article-title":"A review of thymic tumors","volume":"4","author":"Bushan","year":"2013","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2013.0072","article-title":"Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology","volume":"11","author":"Ettinger","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtho.2025.09.013_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102337","article-title":"Risk factors associated with myasthenia gravis in thymoma patients: the potential role of thymic germinal centers","volume":"106","author":"Lefeuvre","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jtho.2025.09.013_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nmd.2023.09.005","article-title":"Myasthenic crisis in thymoma-associated myasthenia gravis: a multicenter retrospective cohort study","volume":"33","author":"Huan","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jtho.2025.09.013_bib20","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ene.14820","article-title":"Clinical characteristics and outcomes of thymoma-associated myasthenia gravis","volume":"28","author":"\u00c1lvarez-Velasco","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jtho.2025.09.013_bib21","article-title":"Long-term prognosis in patients with thymoma combined with myasthenia gravis: a propensity score-matching analysis","volume":"11","author":"Zhao","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtho.2025.09.013_bib22","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.athoracsur.2020.12.010","article-title":"Thymectomy in myasthenic patients with thymoma: killing two birds with one stone","volume":"112","author":"Aprile","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib23","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.21037\/jtd.2018.05.30","article-title":"Inter-relationship among myasthenia gravis, WHO histology, and Masaoka clinical stage and effect on surgical methods in patients with thymoma: a retrospective cohort study","volume":"10","author":"Shen","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2025.09.013_bib24","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00268-017-3990-y","article-title":"A phase II study of partial and subtotal thymectomy for thymoma (JART02)","volume":"41","author":"Yano","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ejcts\/ezab253","article-title":"Robotic thymectomy for thymoma in patients with myasthenia gravis: neurological and oncological outcomes","volume":"60","author":"Romano","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib26","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.3892\/ol.2016.4528","article-title":"Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy","volume":"11","author":"Zhang","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2025.09.013_bib27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/jcm10071537","article-title":"Drugs that induce or cause deterioration of myasthenia gravis: an update","volume":"10","author":"Sheikh","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/ITT.S377056","article-title":"Novel immunotherapies for myasthenia gravis","volume":"12","author":"Nair","year":"2023","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.jtho.2025.09.013_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtho.2025.09.013_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","article-title":"Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience","volume":"135","author":"Thompson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtho.2025.09.013_bib31","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure red cell aplasia","volume":"128","author":"Means","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtho.2025.09.013_bib32","first-page":"187","article-title":"Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment","volume":"67","author":"Janda","year":"2010","journal-title":"Przegl Lek"},{"key":"10.1016\/j.jtho.2025.09.013_bib33","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/blood.2021010898","article-title":"How I manage acquired pure red cell aplasia in adults","volume":"137","author":"Gurnari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtho.2025.09.013_bib34","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1182\/bloodadvances.2023010587","article-title":"Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis","volume":"7","author":"Lobbes","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtho.2025.09.013_bib35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","article-title":"Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome","volume":"289","author":"Rosenfeld","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jtho.2025.09.013_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jcp.56.1.12","article-title":"What is Good\u2019s syndrome? Immunological abnormalities in patients with thymoma","volume":"56","author":"Kelleher","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtho.2025.09.013_bib37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jaip.2023.12.018","article-title":"Unraveling the natural history of Good\u2019s syndrome: a progressive adult combined immunodeficiency","volume":"12","author":"Kabir","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jtho.2025.09.013_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/med-22-12","article-title":"Good\u2019s syndrome and COVID-19: case report and literature review","volume":"7","author":"Berzenji","year":"2022","journal-title":"Mediastinum"},{"key":"10.1016\/j.jtho.2025.09.013_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.679556","article-title":"When the Good syndrome goes bad: a systematic literature review","volume":"12","author":"Shi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18176\/jiaci.0388","article-title":"Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management","volume":"30","author":"Yazdani","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib41","article-title":"Good\u2019s syndrome: time to move on from reviewing the past","volume":"12","author":"Kabir","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.908453","article-title":"Immunological signature of patients with thymic epithelial tumors and Good syndrome","volume":"13","author":"Malfitano","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib43","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jtho.2023.06.015","article-title":"Impaired seroconversion after severe acute respiratory syndrome Coronavirus 2 mRNA vaccine in patients with thymic epithelial tumors","volume":"18","author":"Pietroluongo","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib44","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s12885-024-12405-4","article-title":"COVID-19 in patients with thymic epithelial tumors with or without Good\u2019s syndrome: a single-center retrospective study","volume":"24","author":"Pietroluongo","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtho.2025.09.013_bib45","first-page":"437","article-title":"Pre-B cell suppression by thymoma patient lymphocytes","volume":"48","author":"Hayward","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib46","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood-2002-08-2638","article-title":"Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia","volume":"101","author":"Masci","year":"2003","journal-title":"Blood"},{"issue":"suppl","key":"10.1016\/j.jtho.2025.09.013_bib47","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jmii.2012.09.003","article-title":"Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good\u2019s syndrome","volume":"48","author":"Wang","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jtho.2025.09.013_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2020.12.010","article-title":"Immunodeficiency and thymoma in Good syndrome: two sides of the same coin","volume":"231","author":"Guevara-Hoyer","year":"2021","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jtho.2025.09.013_bib50","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/biomedicines11061605","article-title":"Insights from a case of Good\u2019s syndrome (immunodeficiency with thymoma)","volume":"11","author":"Paganelli","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtho.2025.09.013_bib51","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/ol.2011.501","article-title":"Thymoma associated with fatal myocarditis and polymyositis in a 58-year-old man following treatment with carboplatin and paclitaxel: a case report","volume":"3","author":"Sasaki","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2025.09.013_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.humimm.2011.12.022","article-title":"High prevalence of infections and autoimmunity in patients with thymoma","volume":"73","author":"Holbro","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtcvs.2019.11.052","article-title":"A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases","volume":"160","author":"Zhao","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13317-014-0063-1","article-title":"Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation","volume":"5","author":"Iaccarino","year":"2014","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.jtho.2025.09.013_bib55","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.2214\/AJR.08.1764","article-title":"MRI findings in inflammatory muscle diseases and their noninflammatory mimics","volume":"192","author":"Schulze","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jtho.2025.09.013_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0404.1992.tb03997.x","article-title":"Fulminant myasthenia gravis and polymyositis after thymectomy for thymoma","volume":"85","author":"Hassel","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jtho.2025.09.013_bib57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1023\/A:1008321802223","article-title":"Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide","volume":"10","author":"Rini","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.autrev.2011.06.007","article-title":"Therapy of polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtho.2025.09.013_bib59","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10067-012-1940-5","article-title":"Intravenous immunoglobulin therapy in adult patients with polymyositis\/dermatomyositis: a systematic literature review","volume":"31","author":"Wang","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jtho.2025.09.013_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2023.01.018","article-title":"The efficacy and safety of tacrolimus in patients with dermatomyositis\/polymyositis: a meta-analysis and systematic review","volume":"110","author":"Liao","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/acr2.11493","article-title":"Randomized trial of tocilizumab in the treatment of refractory adult polymyositis and dermatomyositis","volume":"4","author":"Oddis","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jtho.2025.09.013_bib62","first-page":"9","article-title":"Polymyositis and myocarditis after chemotherapy for advanced thymoma","volume":"1","author":"Yamamoto","year":"2013","journal-title":"Cancer Treat Commun"},{"key":"10.1016\/j.jtho.2025.09.013_bib63","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ajg.2009.99","article-title":"Transient autoimmune hepatitis induced by a thymoma","volume":"104","author":"Aigner","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtho.2025.09.013_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.746304","article-title":"Clinical and genetic characteristics of thymoma patients with autoimmune hepatitis and myocarditis","volume":"11","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"suppl","key":"10.1016\/j.jtho.2025.09.013_bib66","doi-asserted-by":"crossref","first-page":"S1269","DOI":"10.14309\/00000434-201810001-02235","article-title":"Thymoma-induced autoimmune hepatitis: a rare paraneoplastic syndrome","volume":"113","author":"Stilwell","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtho.2025.09.013_bib67","first-page":"169","article-title":"Effect of chemotherapy on autoimmune hepatitis in thymoma: a case report and literature review","volume":"10","author":"Mejri","year":"2013","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2169\/internalmedicine.9743-22","article-title":"Concurrent de novo thymoma-associated paraneoplastic type 1 autoimmune hepatitis and pure red cell aplasia after thymectomy: a case report and literature review","volume":"62","author":"Sakata","year":"2023","journal-title":"Intern Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12902-020-0498-5","article-title":"Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report","volume":"20","author":"Inaba","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jtho.2025.09.013_bib70","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12328-022-01641-5","article-title":"A case of autoimmune hepatitis with thymoma and myasthenia gravis","volume":"15","author":"Sakae","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.jtho.2025.09.013_bib71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/icvts\/ivz138","article-title":"Autoimmune hepatitis during preoperative chemotherapy in a patient with thymoma","volume":"29","author":"Nishimura","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"suppl 2","key":"10.1016\/j.jtho.2025.09.013_bib72","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.5301\/tj.5000505","article-title":"Autoimmune hepatitis: an uncommon presentation of thymoma","volume":"102","author":"Mendogni","year":"2016","journal-title":"Tumori"},{"key":"10.1016\/j.jtho.2025.09.013_bib73","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1872-034X.2012.00985.x","article-title":"Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder","volume":"42","author":"Yapali","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jtho.2025.09.013_bib74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3904\/kjim.2000.15.2.151","article-title":"Autoimmune hepatitis in a patient with myasthenia gravis and thymoma -- a report on the first case in korea","volume":"15","author":"Han","year":"2000","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib75","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/JTO.0b013e318298832b","article-title":"Acute autoimmune hepatitis, myositis, and myasthenic crisis in a patient with thymoma","volume":"8","author":"Rajan","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib76","article-title":"Polyparaneoplastic manifestations of malignant thymoma: a unique case of myasthenia, autoimmune hepatitis, pure red cell aplasia, and keratoconjunctivitis sicca","volume":"9","author":"Feinsilber","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.jtho.2025.09.013_bib77","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jtho.2025.09.013_bib78","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jnnp.59.5.558","article-title":"Autoimmune chronic active hepatitis and polymyositis in a patient with myasthenia gravis and thymoma","volume":"59","author":"Ko","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtho.2025.09.013_bib79","first-page":"292","article-title":"A patient with thymoma and four different organ-specific autoimmune diseases","volume":"60","author":"Asakawa","year":"2002","journal-title":"Neth J Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib80","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000458","article-title":"Autoimmune hepatitis: current and future therapies","volume":"8","author":"Reau","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jtho.2025.09.013_bib81","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/cns.14166","article-title":"Thymoma-associated autoimmune encephalitis: analysis of factors determining prognosis","volume":"29","author":"Song","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jtho.2025.09.013_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14568","article-title":"Thymoma-associated autoimmune encephalitis with myasthenia gravis: case series and literature review","volume":"30","author":"Su","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jtho.2025.09.013_bib83","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.jtcvs.2010.10.022","article-title":"Thymoma-associated paraneoplastic encephalitis (TAPE): diagnosis and treatment of a potentially fatal condition","volume":"141","author":"Erkmen","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib84","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001053","article-title":"Thymoma and autoimmune encephalitis: clinical manifestations and antibodies","volume":"8","author":"Guasp","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtho.2025.09.013_bib85","doi-asserted-by":"crossref","first-page":"448","DOI":"10.5761\/atcs.cr.21-00052","article-title":"Thymoma-related stiff-person syndrome with successfully treated by surgery","volume":"28","author":"Sasaki","year":"2022","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib86","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.athoracsur.2013.07.103","article-title":"Recurrent thymoma with stiff-person syndrome and pure red blood cell aplasia","volume":"97","author":"Kobayashi","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib87","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.atssr.2024.01.004","article-title":"Efficacy of surgical treatment for thymoma-related stiff person syndrome","volume":"2","author":"Sumiya","year":"2024","journal-title":"Ann Thorac Surg Short Rep"},{"key":"10.1016\/j.jtho.2025.09.013_bib88","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.athoracsur.2004.02.076","article-title":"Stiff man syndrome with thymoma","volume":"80","author":"Tanaka","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)","volume":"211","author":"Str\u00f6bel","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.jtho.2025.09.013_bib90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jtcvs.2006.03.030","article-title":"Thymectomy for paraneoplastic stiff-person syndrome associated with invasive thymoma","volume":"132","author":"Iwata","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2025.09.013_bib91","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10875-024-01760-3","article-title":"Lymphocyte-directed immunomodulation remits thymoma-associated autoimmune pneumonitis","volume":"44","author":"Ferr\u00e9","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5597","article-title":"Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance","volume":"11","author":"Ferr\u00e9","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib93","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12714","article-title":"Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"287","author":"Constantine","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtho.2025.09.013_bib94","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.31421","article-title":"APECED-associated hepatitis: clinical, biochemical, histological and treatment data from a large, predominantly American cohort","volume":"73","author":"Chascsa","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jtho.2025.09.013_bib95","article-title":"An AIREless breath: pneumonitis caused by impaired central immune tolerance","volume":"11","author":"Ferr\u00e9","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib96","first-page":"117","article-title":"Thymoma accompanied lichen planus: case report review literature","volume":"58","author":"Hayashi","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.jtho.2025.09.013_bib97","article-title":"Oral lichen planus in a patient with a thymoma: a rare finding","volume":"13","author":"Gubod","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jtho.2025.09.013_bib98","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3389\/fimmu.2019.01808","article-title":"Therapeutic targeting of Th17\/Tc17 cells leads to clinical improvement of lichen planus","volume":"10","author":"Solimani","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib99","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib100","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtho.2025.09.013_bib101","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3389\/fimmu.2019.01413","article-title":"Thymoma-associated paraneoplastic autoimmune multiorgan syndrome-from pemphigus to lichenoid dermatitis","volume":"10","author":"Solimani","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2025.09.013_bib102","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtho.2025.09.013_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-229163","article-title":"Thymoma-associated multiorgan autoimmunity","volume":"12","author":"Hung","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jtho.2025.09.013_bib104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/cup.14743","article-title":"Thymoma-associated multiorgan autoimmunity (TAMA) presenting as a graft versus host disease-like erythroderma","volume":"52","author":"Hewitt","year":"2025","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jtho.2025.09.013_bib105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arbr.2017.08.021","article-title":"Leser-Tr\u00e9lat sign secondary to thymic carcinoma","volume":"54","author":"Mendes","year":"2018","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.jtho.2025.09.013_bib106","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJM196101052640108","article-title":"Thymoma associated with myocarditis and the L.E.-cell phenomenon. Report of a case","volume":"264","author":"Funkhouser","year":"1961","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib107","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clineuro.2006.12.010","article-title":"Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis","volume":"109","author":"O\u2019Sullivan","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jtho.2025.09.013_bib108","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00415-022-11485-1","article-title":"Anti-titin antibodies are associated with myocarditis in patients with myasthenia gravis","volume":"270","author":"Kim","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.jtho.2025.09.013_bib109","article-title":"Thymoma-associated myasthenia gravis with myocarditis","volume":"15","author":"Sarwar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jtho.2025.09.013_bib110","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/jdv.19917","article-title":"Cutaneous manifestations thymoma-associated multiorgan autoimmunity: case series","volume":"38","author":"Cara-Gualda","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jtho.2025.09.013_bib111","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1200\/JCO.2011.38.3935","article-title":"Scleromyxedema: a cutaneous paraneoplastic syndrome associated with thymic carcinoma","volume":"30","author":"Chan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib112","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2230.2004.01539.x","article-title":"Acrokeratosis paraneoplastica associated with recurrent metastatic thymic carcinoma","volume":"29","author":"Chave","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jtho.2025.09.013_bib113","first-page":"54","article-title":"Sweet\u2019s syndrome in a patient with idiopathic myelofibrosis and thymoma-myasthenia gravis-immunodeficiency complex: efficacy of treatment with etretinate","volume":"81","author":"Altomare","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.jtho.2025.09.013_bib114","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.07.2009.2091","article-title":"A case of vitiligo vulgaris showing a pronounced improvement after treatment for myasthenia gravis","volume":"2009","author":"Nakamagoe","year":"2009","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jtho.2025.09.013_bib115","article-title":"Tolerability of coronavirus disease 2019 vaccines, BNT162b2 and mRNA-1273, in patients with thymic epithelial tumors","volume":"2","author":"Ballman","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtho.2025.09.013_bib116","author":"Cao"},{"key":"10.1016\/j.jtho.2025.09.013_bib117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/25785826.2022.2129371","article-title":"Thymus variants on imaging of patients with primary Sj\u00f6gren\u2019s syndrome and polymyositis\/dermatomyositis: clinical and immunological significance","volume":"46","author":"Murata","year":"2023","journal-title":"Immunol Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtho.2025.09.013_bib119","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/s41591-024-03009-3","article-title":"CD40 ligand antagonist dazodalibep in Sj\u00f6gren\u2019s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial","volume":"30","author":"St Clair","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jtho.2025.09.013_bib120","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032077","article-title":"Thymoma with systemic lupus erythematosus and immune-related anemia: a case of thymoma with SLE and IRA","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtho.2025.09.013_bib121","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.revmed.2017.03.003","article-title":"Thymomes et maladies auto-immunes [Thymoma and autoimmune diseases]","volume":"39","author":"Jamilloux","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jtho.2025.09.013_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102464","article-title":"Systemic lupus erythematosus associated with thymoma: A fifteen-year observational study in France","volume":"19","author":"No\u00ebl","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"Suppl 5","key":"10.1016\/j.jtho.2025.09.013_bib123","doi-asserted-by":"crossref","first-page":"v40","DOI":"10.1093\/annonc\/mdv277","article-title":"ESMO Guidelines Committee. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Girard","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2025.09.013_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1288045","article-title":"Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs","volume":"15","author":"Perrino","year":"2024","journal-title":"Front Immunol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086425010639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086425010639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:36:19Z","timestamp":1779953779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086425010639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1556086425010639"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2025.09.013","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Autoimmune Conditions Associated With Thymic Epithelial Tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2025.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}